Samuel Blackman
Founder at DAY ONE BIOPHARMACEUTICALS, INC.
Net worth: 29 M $ as of 2024-04-29
Network origin in Samuel Blackman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
| Subsidiary | Biotechnology | 13 | |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
| Extinct | Pharmaceuticals: Major | 3 | |
Mavupharma, Inc.
 Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Samuel Blackman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ASTROTECH CO. | Aerospace & Defense | Comptroller/Controller/Auditor | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| BELLICUM PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Human Resources Officer | |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Pharmaceuticals: Major | Director/Board Member | |
| TESARO INC | Pharmaceuticals: Major | President Director/Board Member | |
Labrys Biologics, Inc.
 Labrys Biologics, Inc. BiotechnologyHealth Technology Labrys Biologics, Inc. provides biotechnology services. It is a venture-financed development stage biotechnology company, which focuses on treatments for chronic migraine. The company was founded by Corey S. Goodman in 2012 and is headquartered in San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| College of the Holy Cross (Massachusetts) | College/University | Director/Board Member Undergraduate Degree | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree Graduate Degree | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Texas at Austin | College/University | Doctorate Degree Doctorate Degree | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| The Pennsylvania State University | College/University | Graduate Degree Undergraduate Degree | |
| SANA BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Public Communications Contact Human Resources Officer Corporate Officer/Principal | |
| University of Connecticut | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Colorado | College/University | Masters Business Admin Doctorate Degree | |
| CHINOOK THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Public Communications Contact | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Director/Board Member | |
Nocion Therapeutics, Inc.
 Nocion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nocion Therapeutics, Inc. is a biopharmaceutical company, which targets neurons mediating cough, itch, pain and inflammation without the addictive properties of opioids. The company was founded by Bruce Bean, Clifford Woolf and Bruce David Levy and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal | |
Genentech Ventures, Inc.
 Genentech Ventures, Inc. Investment ManagersFinance Genentech Ventures (Genentech Ventures) is a venture capital firm founded in 1900. The firm is headquartered in South San Francisco, CA. | Investment Managers | Corporate Officer/Principal | |
Synthekine, Inc.
 Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member | |
| Weber State University | College/University | Undergraduate Degree | |
| Stanford University School of Medicine | College/University | Doctorate Degree | |
| EDGEWISE THERAPEUTICS, INC. | Biotechnology | Founder | |
| NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member | |
XTuit Pharmaceuticals, Inc.
 XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology XTuit Pharmaceuticals, Inc. develops drugs for the treatment of cancer. The firm develops pharmaceutical products for use in the diagnosis and treatment of oncological, tumor and inflammatory diseases. The company was founded by Alan L. Crane, Rakesh Kumar Jain, Andrew Werk Cook, Edwin L. Steele, David H. Koch, Ronald Evans, Howard Hughes and Robert S. Langer, Jr. in 2011 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
| McCombs School of Business | College/University | Masters Business Admin | |
The Pfizer Foundation, Inc.
 The Pfizer Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., The Pfizer Foundation, Inc. is a company committed to transparency and disclosure of activities of public interest. The company is based in New York, NY. Pfizer is dedicated to discovering breakthrough treatments, including medicines and vaccines, to benefit patients worldwide. The company is focused on treating 225 million people with these breakthrough treatments by 2025. The company's areas of interest include funding for educational activities, health education, and scientific research. Additionally, Pfizer is exploring the potential of mRNA technology to fight viruses and is working to understand the differences between biologics and biosimilars, particularly in terms of cost. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
| United States | 45 |
| Switzerland | 2 |
| Australia | 2 |
| United Kingdom | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 15 |
| Commercial Services | 4 |
| Finance | 3 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 211 |
| Corporate Officer/Principal | 92 |
| Independent Dir/Board Member | 82 |
| Chief Executive Officer | 33 |
| Undergraduate Degree | 33 |
Most connected contacts
| Insiders | |
|---|---|
| Maggie Wilderotter | 43 |
| Thomas Daniel | 35 |
| Robert F. Baltera | 23 |
| Michael Gladstone | 23 |
| Sona Saira Ramasastry | 19 |
| Hyam Levitsky | 18 |
| Derek DiRocco | 17 |
| Hal Barron | 16 |
| Dan Becker | 16 |
| Robert Azelby | 15 |
| Saqib Islam | 15 |
| Eric Dobmeier | 14 |
| Garry Nicholson | 14 |
| Julie Grant | 13 |
| J. Garland | 13 |
- Stock Market
- Insiders
- Samuel Blackman
- Company connections
